These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
11. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. Khan FZ; Perumpail RB; Wong RJ; Ahmed A World J Hepatol; 2015 Aug; 7(18):2155-61. PubMed ID: 26328027 [TBL] [Abstract][Full Text] [Related]
12. FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases. Tillman EJ; Rolph T Front Endocrinol (Lausanne); 2020; 11():601290. PubMed ID: 33381084 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review. Eguchi Y; Wong G; Lee EI; Akhtar O; Lopes R; Sumida Y JGH Open; 2020 Oct; 4(5):808-817. PubMed ID: 33102749 [TBL] [Abstract][Full Text] [Related]